Project description
Antibody sequencing opens new opportunities in medical research
The antibody repertoire in the adaptive human immune system evolved to tackle the great number of pathogens (bacteria, viruses) and exogenous threats (toxins). Understanding which antibodies are produced in response to a particular pathogen can pave the way towards more efficient and personalised therapies. To address this issue, the EU-funded TopSpec project has developed an improved platform based on mass spectrometry for the sequencing of antibodies. Alongside a high-performance data acquisition system and data processing and analysis software, TopSpec will significantly increase the opportunities in medical research and drug development and expand our knowledge of the immune system.
Fields of science
- natural sciencesphysical sciencesnuclear physicsnuclear fission
- natural sciencescomputer and information sciencessoftware
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsproteomics
- natural scienceschemical sciencesanalytical chemistrymass spectrometry
- natural sciencescomputer and information sciencesdata sciencedata processing
Programme(s)
Funding Scheme
RIA - Research and Innovation action
Coordinator
17177 Stockholm
Sweden
See on map
Participants (7)
153 41 Agia Paraskevi
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
28199 Bremen
See on map
1015 Lausanne
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
18348 Stockholm
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
NG1 4FQ Nottingham
See on map
75724 Paris Cedex 15
See on map
1322 AM Almere
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.